BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38432603)

  • 1. Effectiveness and safety of minocycline combination therapy for the treatment of patients with ventilator-associated pneumonia due to extensively drug- or pandrug-resistant Acinetobacter baumannii.
    Athanassa Z; Manioudaki S; Petsa I; Koumaki V; Sakagianni A; Tsakris A
    Int J Antimicrob Agents; 2024 May; 63(5):107129. PubMed ID: 38432603
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of resolution of infectious parameters in multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Myrianthefs P; Ioannides K; Gavala A; Evodia E; Tsakris A; Baltopoulos G
    J Hosp Infect; 2010 May; 75(1):79-80. PubMed ID: 20303615
    [No Abstract]   [Full Text] [Related]  

  • 4. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
    Chaari A; Pham T; Mnif B; Chtara K; Medhioub F; Baccouche N; Bahloul M; Hammami A; Bouaziz M
    Intensive Care Med; 2015 Nov; 41(11):2018-9. PubMed ID: 26264246
    [No Abstract]   [Full Text] [Related]  

  • 5. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
    Qin Y; Zhang J; Wu L; Zhang D; Fu L; Xue X
    Int J Clin Pharmacol Ther; 2018 Mar; 56(3):120-129. PubMed ID: 29319497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
    Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
    J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
    Kengkla K; Kongpakwattana K; Saokaew S; Apisarnthanarak A; Chaiyakunapruk N
    J Antimicrob Chemother; 2018 Jan; 73(1):22-32. PubMed ID: 29069421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
    Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M
    New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Aydemir H; Akduman D; Piskin N; Comert F; Horuz E; Terzi A; Kokturk F; Ornek T; Celebi G
    Epidemiol Infect; 2013 Jun; 141(6):1214-22. PubMed ID: 22954403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii].
    Wang LW; Zou L; Li HX; Li TZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Apr; 36(2):185-8. PubMed ID: 24791800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
    Goff DA; Kaye KS
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular characterization of a multidrug-resistant/pandrug-resistant nosocomial polymicrobial infection with Klebsiella pneumoniae, Providencia rettgeri, and Acinetobacter baumannii from Rural Maharashtra, India.
    Karad DD; Somani Y; Khande H; Yadav B; Kharat AS
    Acta Biochim Pol; 2020 Jul; 67(3):387-392. PubMed ID: 32735431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilator-Associated Pneumonia due to Drug-Resistant
    Čiginskienė A; Dambrauskienė A; Rello J; Adukauskienė D
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30781896
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Kalin G; Alp E; Akin A; Coskun R; Doganay M
    Infection; 2014 Feb; 42(1):37-42. PubMed ID: 23828559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
    J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracyclines for multidrug-resistant Acinetobacter baumannii infections.
    Falagas ME; Vardakas KZ; Kapaskelis A; Triarides NA; Roussos NS
    Int J Antimicrob Agents; 2015 May; 45(5):455-60. PubMed ID: 25801348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
    Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.